wet-age-related-macular-degeneration-market-analysis
Press Release

Wet Age-Related Macular Degeneration (Wet-AMD) is a type of macular degeneration in which abnormal blood vessels (known as choroidal neovascularization or CNV) develop under the retina and macula. These abnormal blood vessels often grow and leak or bleed, causing scarring of the macula. This damage to the macula results in rapid central vision loss. Once this vision is destroyed, it cannot be restored. Wet AMD results into the exudation or leakage of fluid and blood from new blood vessels and also called neovascular AMD or exudative AMD. Most AMD starts as the dry type and in 10-20% of individuals, it progresses to the wet type. Age-related macular degeneration is always bilateral (i.e., occurs in both eyes), but does not necessarily progress at the same pace in both eyes.

 

Visit For Sample Pages: 

https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-market

 

DelveInsight’s “Wet Age-Related Macular Degeneration Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Wet Age-Related Macular Degeneration, historical and forecasted epidemiology as well as the Wet Age-Related Macular Degeneration market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Wet Age-Related Macular Degeneration market report aslo covers emerging drugs, current treatment practices, Wet Age-Related Macular Degeneration market share of the individual therapies, current and forecasted Wet Age-Related Macular Degeneration Market Size from 2017 to 2030 segmented by seven major markets. The report provides a detailed current Wet Age-Related Macular Degeneration treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market. 

 

Wet Age-Related Macular Degeneration Market Key Facts

  • The National Eye Institute (NEI) states that women generally are more susceptible to develop age-related eye diseases, such as AMD. In 2010, 65 percent of total AMD cases were in women as compared to 35 percent in men.
  • Approximately 200,000 new cases of Wet AMD are diagnosed each year in the U.S and Wet AMD results in the cause of 90% of AMD-related severe vision loss.
  • The number of people living with macular degeneration is expected to reach 196 million worldwide by 2020 and increase to 288 million by 2040.
  • The number of neovascular AMD cases in the UK is predicted to rise by 59% from 2015 to 2035
  • Nearly 11 million Americans have some form of macular degeneration, while 1.1 million or 10% of those Americans have wet AMD

 

Key Benefits of Wet Age-Related Macular Degeneration Market Report

  • Wet Age-Related Macular Degeneration market report provides an in-depth analysis of Wet Age-Related Macular Degeneration Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.
  • The Wet Age-Related Macular Degeneration market report will help in developing business strategies by understanding the Wet Age-Related Macular Degeneration Market trends & developments, key players and future market competition that will shape and drive the Wet Age-Related Macular Degeneration market in the upcoming years.
  • The Wet Age-Related Macular Degeneration market report covers Wet Age-Related Macular Degeneration current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
  • The report provides a detailed assessment of the Wet Age-Related Macular Degeneration market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population,  comparative analysis of pipeline products with detailed clinical profiles, and other factors. 

 

Wet Age-Related Macular Degeneration Market

The Wet Age-Related Macular Degeneration market outlook section of the report helps to build the detailed comprehension of the historic, current and forecasted Wet Age-Related Macular Degeneration market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology. 

The report gives a thorough detail of Wet Age-Related Macular Degeneration market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders. 

 

Wet Age-Related Macular Degeneration Epidemiology

The Wet Age-Related Macular Degeneration epidemiology section covers insights about historical and current Wet Age-Related Macular Degeneration patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.

It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

 

Wet Age-Related Macular Degeneration Drugs Uptake and Key Market Players

The Wet Age-Related Macular Degeneration Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Wet Age-Related Macular Degeneration market or expected to get launched in the market during the study period. The analysis covers Wet Age-Related Macular Degeneration market uptake by drugs; patient uptake by therapies; and sales of each drug.    

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The key players in Wet Age-Related Macular Degeneration market include: 

  • Allergan
  • Bioeq
  • Alkahest
  • Graybug Vision
  • EyePoint Pharmaceuticals

and others

 

Visit For Sample Pages: 

https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-market

 

Table of Content

  1. Key Insights
  2. Executive Summary 
  3. Wet Age-Related Macular Degeneration Competitive Intelligence Analysis
  4. Wet Age-Related Macular Degeneration Market Overview at a Glance
  5. Wet Age-Related Macular Degeneration Disease Background and Overview
  6. Wet Age-Related Macular Degeneration Patient Journey
  7. Wet Age-Related Macular Degeneration Epidemiology and Patient Population
  8. Wet Age-Related Macular Degeneration Treatment Algorithm, Current Treatment, and Medical Practices
  9. Wet Age-Related Macular Degeneration Unmet Needs
  10. Key Endpoints of Wet Age-Related Macular Degeneration Treatment
  11. Wet Age-Related Macular Degeneration Marketed Products
  12. Wet Age-Related Macular Degeneration Emerging Therapies
  13. Wet Age-Related Macular Degeneration Seven Major Market Analysis
  14. Attribute Analysis
  15. Wet Age-Related Macular Degeneration Market Outlook (7 major markets)
  16. Wet Age-Related Macular Degeneration Access and Reimbursement Overview
  17. KOL Views on the Wet Age-Related Macular Degeneration Market.
  18. Wet Age-Related Macular Degeneration Market Drivers
  19. Wet Age-Related Macular Degeneration Market Barriers
  20. Appendix
  21. DelveInsight Capabilities
  22. Disclaimer

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.

 

Related Reports-

Wet Age-Related Macular Degeneration (Wet AMD) – Epidemiology Forecast to 2030

DelveInsight’s Wet Age-Related Macular Degeneration (Wet AMD) – Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Wet Age-Related Macular Degeneration (Wet AMD) in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

 

Wet Age-Related Macular Degeneration (Wet AMD) – Pipeline Insights, 2020

Wet Age-Related Macular Degeneration (Wet AMD) Pipeline Insight, 2020 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Wet Age-Related Macular Degeneration (Wet AMD) market.

 

Contact us:

Shruti Thakur

[email protected] 

+91-9650213330

https://www.delveinsight.com/

https://www.delveinsight.com/report-store/wet-age-related-macular-degeneration-wet-amd-market